Today's Top SOA Links
From the Wires
Syneron Medical Appoints Jonathan Pearson as Executive Vice President of Business Development, Topical Products
By: PR Newswire
Nov. 7, 2012 07:25 AM
YOKNEAM, Israel, Nov. 7, 2012 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), www.syneron.com, the leading global aesthetic device company, announced today that Jonathan Pearson has been appointed Executive Vice President of Business Development, Topical Products, effective November 19, 2012. In this position, Mr. Pearson will have global responsibility for Syneron's business of topical cosmetic products, which currently includes the elure™ Advanced Skin Brightening product family. He will report to Louis P. Scafuri, Chief Executive Officer of Syneron.
Prior to joining Syneron, from 2003 to 2012, Mr. Pearson was a corporate officer at TRIA Beauty, Inc., a developer and marketer of light-based skincare products for use in the home. Mr. Pearson was a co-founder of the company and served as Asia Pacific Region Manager, with direct responsibility for establishing and managing the company's Asian operations. Prior to co-founding TRIA Beauty, Mr. Pearson was employed from 2001 to 2003 at Lumenis, Ltd., a developer, manufacturer and distributor of a broad range of medical lasers and energy delivery equipment for surgical, aesthetic and ophthalmic applications. At Lumenis, Mr. Pearson was Executive Vice President, Asia-Pacific Operations, and served as a corporate officer. Mr. Pearson joined Lumenis when it merged with Coherent Inc., where he served from 1994 to 2001, ultimately as Director, Asia-Pacific, managing the company's direct operations in Japan and the People's Republic of China.
Mr. Pearson holds a bachelor's degree in Political Science from the University of Washington and a master's degree in International Management from Thunderbird School of Global Management. He is bi-lingual in the English and Japanese languages, and has extensive experience living in Asia.
Mr. Scafuri, said, "Jon Pearson has a proven track record of success in the aesthetic industry, with unique and relevant global experience in both the professional and consumer markets. We believe he is ideally suited to help us capitalize on the tremendous opportunity for our elure™ Advanced Skin Brightening product family, as well as further expand the topical segment of our business. His deep familiarity with and understanding of Asian markets will be particularly valuable, given that this geography represents the largest opportunity for elure™. We look forward to welcoming Jon to the team and collaborating with him to grow our topical business."
About Syneron Medical Ltd.
SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS
In addition, the statements in this document reflect the expectations and beliefs of Syneron Medical Ltd. as of the date of this document. Syneron Medical Ltd. anticipates that subsequent events and developments will cause its expectations and beliefs to change. However, while Syneron Medical Ltd. may elect to update these forward-looking statements publicly in the future, it specifically disclaims any obligation to do so. The forward-looking statements of Syneron Medical Ltd. do not reflect the potential impact of any future dispositions or strategic transactions that may be undertaken. These forward-looking statements should not be relied upon as representing Syneron Medical Ltd.'s views as of any date after the date of this document.
SOURCE Syneron Medical Ltd.
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week